Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex

Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

(2012) Cédric M. Hysek et al.   PLoS One

The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

(2011) C M Hysek et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Contradictory Effects of β1- and α1- Aderenergic Receptor Blockers on Cardio-Ankle Vascular Stiffness Index (CAVI)

(2011) Kohji Shirai et al.   Journal of Atherosclerosis and Thrombosis

Sex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects

(2011) Linda D. Simmler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Two separate dose-dependent effects of paroxetine: mydriasis and inhibition of tramadol’s O-demethylation via CYP2D6

(2010) Anette Green Nielsen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

(2010) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker

(2009) L. Noehr-Jensen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration

(2009) Erin A. Kolbrich et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers

(2009) Vassilis Koudas et al.   PSYCHOPHARMACOLOGY

Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature

(2008) Bart Roelands et al.   JOURNAL OF APPLIED PHYSIOLOGY